Generate an explanation for the given claim using the provided supporting material from the paragraph. Please consider the following points while generating an output. 1) The claim will always have supporting proof in the paragraph, and the paragraph will have a clear point of view supporting the claim. 2) There can be instances where direct correlation to the claim is not available. Make use of the sentences in the paragraph to provide a corresponding output supporting the claim. 3) The explanation should be at least one and at most twelve sentences long.

Input: Consider Input: Paragraph: Roughly half of Yellowstone's 4,600 bison are estimated to have been exposed to brucellosis, a bacterial infection that can sometimes cause cows and bison to miscarry. Worries that infected bison may endanger cattle in states such as Montana that border Yellowstone had prompted the powerful ranching lobby to endorse biobullets - absorbable projectiles packed with vaccine. They would cut disease rates among bison by as much as 35 percent over 30 years. The proposal was the latest decades-long efforts to ease conflicts between livestock interests and wildlife advocates over management of Yellowstone bison. Park officials said they decided against the remote vaccination program because of its $9 million price tag, questions about its effectiveness and the possible impact on the millions of visitors who flock to the park to view iconic Western wildlife like bison. The measure would have required shooting the animals once a year for three decades, raising questions about how increased human interaction could affect bison within the wild herd. "We have concerns about how that repeated contact might impact bison behavior and their visibility to park visitors," said Yellowstone spokesman Al Nash. Nash said there was no documented case of wild bison transmitting brucellosis to cattle, which he said signifies the success of existing measures designed to separate the park's herd from domestic livestock. Those practices include returning bison that leave the park, testing and vaccinating bison that leave Yellowstone, and slaughtering some infected animals. Errol Rice, executive vice president of the Montana Stockgrowers Association, said the threats posed by infected bison to Montana's brucellosis-free certification, which protects the market value of cattle, warranted using biobullets. He said the program would have lessened the public outcry that erupts when wandering bison are corralled and shipped to slaughterhouses. "The capture and removal of bison has been a challenging issue for the park and Montana. Remote vaccination would have helped alleviate the public relations burden we have to deal with when bison migrate out of Yellowstone," he said. Stephany Seay, spokeswoman for Buffalo Field Campaign, a bison advocacy group, applauded the park's decision not to shoot bison with vaccine. "It was a mismanagement scheme based on a livestock model. We don't vaccinate skunks against rabies or mosquitoes against West Nile virus," she said. Claim: Yellowstone managers reject vaccinating bison with biobullets.

Output: Yellowstone National Park managers have rejected a plan to use air rifles to shoot the nation's last herd of purebred bison with so-called biobullets containing a vaccine against a cattle disease, in a decision that has riled the U.S. livestock industry.

Input: Consider Input: Paragraph: "There was no discussion of costs of vegetable consumption. Although this could be considered general knowledge, mention of typical costs for vegetables would have been a nice addition. The research on which this story was based compared increasing amounts of vegetable (or fruit and vegetable, or fruit) intake with intake of 0 1.1 servings per day. The study actually only found a statistically significant improvement in the rate of decline for individuals eating 2.5 or more servings of vegetables per day. The story said the effect came with "more than two servings of vegetables per day"" which is too imprecise. In addition, the benefit to be obtained through increased vegetable consumption was characterized as people appearing 5 years younger at the end of the six-years or having 40 percent less mental decline It would have been helpful to provide some idea of the difference this actually represents. The five-year appearance change estimate comes directly from the discussion section of the research paper though the authors of that paper did not provide details on how they arrived at the estimate. This story was not actually about a treatment per se but rather about the possible association between an eating pattern and age-related decline in function. This story reported on a prospective study of cognitive decline in older individuals. Although it did not explicitly mention the nature of the study design, the story included the caveat that the findings don't prove that vegetables reduce mental decline, but add to mounting evidence pointing in that direction. The story would have been stronger if it had included information on the methodology for assessing dietary intake. No obvious elements of disease-mongering The story used several different sources. This story did not discuss other means to delay or diminish the rate of cognitive decline with age. This story reported on a study of vegetable and fruit consumption in older adults in the Chicago area vegetables and fruits that are clearly widely available. The story begins, ""New research on vegetables and aging gives mothers another reason to say 'I told you so.' "" Clearly, this is not a new idea, but the story is about new evidence. Because the story used multiple sources, it does not appear to have relied solely or largely on a news release." Claim: Study: Vegetables may keep brains young

Output: This story presented the results from a recent study which found a slower decline in mental sharpness in older people who ate 2.5 or more servings of vegetables per day than in people who ate 0 1.1 servings of vegetables per day. The story said the effect came with "more than two servings of vegetables per day" which is too imprecise. In addition, the benefit to be obtained through increased vegetable consumption was characterized as people appearing five years younger at the end of the six-years or having 40 percent less mental decline. It would have been more helpful to frame for the reader the amount of mental decline typically seen in the age group studied, what the decline represents in terms of function, and the amount of potential for benefit to be gained through increased vegetable consumption. The five-year appearance change estimate comes directly from the discussion section of the research paper though the authors of that paper did not provide details on how they arrived at the estimate. It was useful that the story pointed out that the research found an association between vegetable intake but not for fruit intake. Although the standard wisdom is to eat a diet rich in fruits and vegetables, this story provides a distinction between these two for readers to consider. It would have been useful for the story to provide a little more clarity about the definition of 'vegetable' for the reader. This study was interesting in that, unlike the USDA, it did not include potatoes in its vegetable count. In addition, it should be pointed out that whereas the FDA's Dietary Guidelines for Americans recommends the equivalent of four to 13 servings a day of vegetables and fruit in a typical 2,000 calorie diet, the benefit in this study was seen at a much lower level 2.5 servings/day of vegetable consumption.

Input: Consider Input: Paragraph: Bayer acquired Monsanto this year for $63 billion. "If we can settle nuisances at some point where the defense costs in preparing cases are higher than potential settlement amounts, we will of course consider it from an economic standpoint," CEO Werner Baumann told reporters when asked whether there was any scenario in which Bayer would consider settling. He added: "We will resolutely and with all means defend ourselves in this (glyphosate) litigation." Baumann was speaking on Monday to German media invited to visit Bayer's new operations in the former research and development facilities of Monsanto in St. Louis, Missouri. The remarks, made on Monday, were embargoed to the end of the week to allow media to return home. Shares in Bayer have lost 25 percent in value since Aug. 10, when a San Francisco jury awarded $289 million to Dewayne Johnson on grounds Monsanto failed to warn the school groundskeeper and other consumers of the cancer risks posed by glyphosate-based RoundUp and Ranger Pro. Johnson has terminal non-Hodgkin's lymphoma that he alleges was caused by the herbicides. A judge later reduced the award to $78 million. Bayer denies that glyphosate causes cancer and says decades of scientific studies and real-world use have shown the chemical to be safe for human use. The company is appealing the findings. The number of glyphosate cases that Bayer faces across the United States has jumped to more than 8,700, prompting concerns among investors about the impact of litigation costs on Bayer's bottom line. Baumann expressed confidence that Bayer could handle the litigation, and cited its "inexpensive" $12 million settlement of 4,000 lawsuits over its contraceptive Mirena device. Bayer also won five of six trials over its best-selling bloodthinner Xarelto, over which it faces 24,000 U.S. lawsuits. The sixth jury found in favor of a plaintiff, but a judge later overturned the decision. "Due to our exposure as a pharmaceutical company, we have the experience to defend those (glyphosate) cases," he said. Baumann said the company's legal strategy had been revised following the integration of Bayer and Monsanto in mid-August. He declined to provide details, but recent court filings reveal some of the steps the company has taken. Last week, Bayer added the attorneys from law firm Arnold & Portner who won the Xarelto cases for the company to its glyphosate defense team. It is also trying to change the juror selection process for upcoming trials. In filings last week in San Francisco federal court, where a new glyphosate trial is scheduled to begin on Feb. 25, 2019, Bayer said the "jury pool likely has grown more hostile" due to negative media coverage following the Johnson verdict. Michael Miller, one of the attorneys for the plaintiff, said the company's claims were "hypocritical beyond belief" given its own efforts to control the message on glyphosate, most recently in a full-page advertisement in the Washington Post. Bayer has asked U.S. District Judge Vince Chhabria, who is overseeing the San Francisco case and some 580 others, to significantly expand the jury pool and question prospective jurors about their knowledge of the media coverage of the cases. Chhabria is expected to decide on the requests in December. Claim: Bayer CEO says would consider glyphosate settlement depending on costs.
Output: Bayer AG's chief executive said this week the company might consider settling lawsuits over Monsanto's glyphosate-containing weed-killers depending on how high court costs rise, but stressed it remained focused on defending the combined company against claims they cause cancer.